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Mammalian models of longevity are related
primarily to caloric restriction and alterations in
metabolism. We examined mice in which type
5 adenylyl cyclase (AC5) is knocked out (AC5
KO) and which are resistant to cardiac stress
and have increased median lifespan of 30%.
AC5 KO mice are protected from reduced bone
density and susceptibility to fractures of aging.
Old AC5 KO mice are also protected from ag-
ing-induced cardiomyopathy, e.g., hypertrophy,
apoptosis, fibrosis, and reduced cardiac func-
tion. Using a proteomic-based approach, we
demonstrate a significant activation of the Raf/
MEK/ERK signaling pathway and upregulation
of cell protective molecules, including superox-
ide dismutase. Fibroblasts isolated from AC5
KO mice exhibited ERK-dependent resistance
to oxidative stress. These results suggest that
AC is a fundamentally important mechanism
regulating lifespan and stress resistance.
INTRODUCTION
Caloric restriction (CR) is a well-recognized mechanism
mediating lifespan extension from yeast to mammals (Sin-
clair, 2005). Other mammalian models of longevity are
related to CR through effects on metabolism, e.g., growth
hormone (GH)/GH receptor (Bluher et al., 2003; Brown-
Borg et al., 1996), and either those involved in the insulin
signaling pathway or insulin-like growth factor receptors,
and stimulation of foxo family transcription factors, result-
ing in prolongation of the maximum lifespan (Kenyon,
2005; Liang et al., 2003).
The current investigation reports a novel mammalian
model of longevity based on interruption of beta-adrenergic
receptor (b-AR) signaling at the level of AC, specifically
disruption of the AC5 gene, an AC isoform predominantlyexpressed in the heart and brain. AC is a key enzyme that
catalyzes the synthesis of cAMP from ATP. cAMP acti-
vates protein kinase A (PKA; Walsh et al., 1968) and regu-
lates the function of multiple proteins and transcriptional
factors, such as CREB and ICER (Houslay and Kolch,
2000). AC also plays a pivotal role in b-AR signaling. At
least nine membrane-bound isoforms of AC (AC1AC9)
exist, with diverse tissue distribution, biochemical proper-
ties, and specific catalytic activities (Hanoune and Defer,
2001). We generated a genetically engineered mouse
model in which AC5 is knocked out (AC5 KO; Okumura
et al., 2003b). Unexpectedly, AC5 KO mice live signifi-
cantly longer than control littermates. The hearts of these
mice also demonstrate resistance to stresses, including
pressure overload and catecholamine stimulation, in
terms of maintenance of cardiac function and protection
against apoptosis (Okumura et al., 2003c).
Another potentially important clinical correlation in-
volves insights into cardioprotection for heart failure since
there is considerable current interest in inhibition of b-AR
signaling and AC for the treatment of heart failure (Bristow,
2000). In view of the parallel features of heart failure
protection and longevity, it is interesting to speculate
that the proteins in the b-AR signaling pathway may be
involved in both longevity and stress resistance.
In this study, we demonstrate that AC5 KO mice exhi-
bit significantly extended median/maximum lifespan, re-
tarded aging phenotypes in the heart and bone, and
increased stress resistance. Using unbiased proteomic
approaches, we found that AC5 KO leads to upregulation
of the Raf/MEK/ERK signaling pathway, which in turn
mediates upregulation of superoxide dismutase (SOD),
an important mechanism mediating lifespan extension
and stress resistance.
RESULTS
AC5 KO Mice Exhibit Extended Lifespan
To determine the lifespan of AC5 KO mice, we first con-
ducted a retrospective study comparing the survival rateCell 130, 247–258, July 27, 2007 ª2007 Elsevier Inc. 247
of WT and AC5 KO mice, which were all alive at 17 months
(Figure 1 insert). Of these, only 16% of WT were still alive
at 30 months of age, whereas 92% of AC5 KO mice re-
mained alive at this time. Next we conducted an antero-
spective study, which is summarized by the Kaplan-Meier
survival analysis. This study revealed that the median life-
span was increased by 8 months (from 25 to 33 months),
p < 0.01, and the maximum lifespan was extended by
4 months (from 33 to 37 months), p < 0.02, in AC5 KO
mice (Figure 1). Increased lifespan was similar in both
males and females. For comparisons of AC5 KO and
WT, young mice (3–6 months) and old mice (20–30
months) were studied.
Bone Quality Is Preserved in Old AC5 KO Mice
Bone integrity was only studied in female mice. Necrop-
sies revealed weakened bone structure with susceptibil-
ity to fractures in old WT mice, but not in old AC5 KO
mice. Radiographs indicated reduced bone density, heal-
ing stress fractures, reduced calcification, and absence
of the fibula in old WT mice (Figure 2A). In contrast,
bones appeared normal in radiographs of old AC5 KO
mice (Figure 2A). The differences in bone structure
were quantified by torsional mechanical testing (Mani-
grasso and O’Connor, 2004). Figure 2B shows three indi-
ces of (femur) bone strength in WT and AC5 KO mice.
The bone peak torque, shear modulus, and shear stress
were greater in AC5 KO mice, demonstrating that the
bone in aging AC5 KO mice is stronger and more resis-
tant to stress.
AC5 KO Mice Have Lower Body Weights and Lower
GH Levels
Reduced body weight (BW) and GH signaling have been
observed in CR mice and several other genetic mutations
(Al-Regaiey et al., 2005; Bartke and Brown-Borg, 2004;
Coschigano et al., 2000; Miller, 1999; Miller et al., 2002)
that lead to increased lifespan. In order to determine
whether knocking out AC5 affects mouse BW and GH sig-
naling, we measured BW and GH levels in AC5 KO mice.
Body weights were found to be similar in young AC5 KO
and WT mice, but significantly decreased in old AC5 KO
compared to old WT mice (p < 0.05). A significant reduc-
tion (p < 0.05) in the GH level was also observed in AC5
KO mice (Figures S1A and S1B). In view of the lower
body weights in AC5 KO mice, we examined whether
CR contributes to the extended lifespan in AC5 KO
mice. We measured food intake in young AC5 KO mice
and WT controls over a 3 week period. The data demon-
strated that AC5 KO mice tend to eat more than WT.
Thus, lifespan extension in AC5 KO is not caused by re-
duced caloric intake in young animals. It is still possible
that older AC5 KO eat less (Figure S1C).
AC5 KO Mice Are Protected
from Aging-Induced Cardiomyopathy
We measured the key features of aging cardiomyopathy
including left ventricular (LV) weight/BW (LVW/BW) ratio,248 Cell 130, 247–258, July 27, 2007 ª2007 Elsevier Inc.myocyte size, LV ejection fraction (LVEF), apoptosis, and
fibrosis. LVW/BW ratio (Figure 3A), an index of LV hyper-
trophy (LVH), was not different between young WT and
AC5 KO mice but was significantly elevated in old WT
(p < 0.05) and not in old AC5 KO mice. Myocyte cross-
sectional area was significantly less, p < 0.02, in old AC5
KO (259.5 ± 4.9 mm2) than in old WT mice (282.9 ± 5.2
mm2), confirming that less LVH developed in old AC5 KO
mice. LVEF (Figure 3B), an index of LV systolic function,
was significantly higher in old AC5 KO mice compared
to old WT mice (p < 0.05), indicating better LV function.
Myocardial fibrosis was increased in old versus young
WT, p < 0.05, but was not increased in old AC5 KO mice
(Figure 3D).
Aging cardiomyopathy is also characterized by in-
creased apoptosis, which was also observed in the pres-
ent study in the old WT mice, but not in the old AC5 KO
mice (Figure 3C). One important signaling pathway
mediating cell survival involves ERK signaling (see below).
Several downstream apoptosis-related elements of this
pathway, e.g., RSK, p-Bad, and Bcl-xl, were significantly
increased in heart, kidney, and brain of AC5 KO mice
(Figure S2A). Other antiapoptotic markers such as XIAP
and Hsp70 were also increased in AC5 KO mice
(Figure S2B), consistent with protection from apoptosis
in AC5 KO mice.
Figure 1. Extended Lifespan in AC5 KO Mice
A retrospective study of WT (n = 25) and AC5 KO mice (n = 13) demon-
strated significant differences in longevity between WT and AC5 KO,
which were alive at 17 months (insert). At 30 months, only 16% of
WT mice survived, whereas 92% of AC5 KO mice were still alive.
The Kaplan-Meier survival curve shows significantly increased sur-
vival, p < 0.01, of AC5 KO mice (n = 14) compared to their WT litter-
mates (n = 17) studied anterospectively from birth to death. The dotted
line indicates the time of 50% survival. Roughly 50% of WT mice died
by 25 months. In striking contrast, 50% of AC5 KO mice died by 33
months. These differences are significant, p < 0.01. The maximum sur-
vival was also significantly different, p < 0.02, by the chi-square test.
Data for males and females were pooled since there were no gender
differences for survival.
Figure 2. Bone Integrity Is Maintained in
Aging AC5 KO Mice
The data obtained in (A) and (B) were from six
female AC5 KO and five female WT mice at
20–25 months old. (A) Radiographs taken of
the tibia of WT and AC5 KO mice. The WT
mice exhibit reduced bone density, apparent
healing stress fractures, reduced calcification,
and absence of the fibula. This was not
observed in AC5 KO mice of the same age. In
this example, both the WT and AC5 KO mice
were 23 months old.
(B) Three indices of bone strength and integrity
comparing old WT (open bars) and old AC5 KO
(solid bars) mice. All three indices—peak torque
(left), shear modulus (middle), and shear stress
(right)—were measured by torsional mechanical
testing and were significantly greater (*p < 0.05)
in AC5 KO, demonstrating that the bone in AC5
KO is stronger and more resistant to stress,
which supports the example shown in Figure 2A.
Data are expressed as mean ± SEM.AC5 KO Mice Are Resistant to Oxidative Stress
To test the hypothesis that knocking out AC5 renders
cells resistant to environmental stresses, we investigated
whether neonatal AC5 KO cardiac myocytes and fibro-
blasts from AC5 KO embryos and adult AC5 KO mice
are resistant to oxidative (H2O2) and DNA (UV light) dam-
age. Cardiac myocytes were isolated from 1-day-old
neonates of homozygous AC5 KO mice or WT mice.
After culture for 48 hr, cells were treated by H2O2 (25,
50, and 100 mM) or UV light (10 and 25 mJ/cm2) for
24 hr. Cell viability was higher in AC5 KO than in WT my-
ocytes (Figure 4A, left upper and lower panels). Mouse
embryonic fibroblasts (MEFs) were isolated from 13 day
embryos of homozygous AC5 KO mice or WT mice.
The third passage cells were treated by H2O2 (50, 100,
200, and 400 mM) or UV light (25 and 100 mJ/cm2) for
24 hr. The proportion of surviving cells was higher in
AC5 KO than in WT MEFs (Figure 4A, right upper and
lower panels). Furthermore, fibroblasts were grown
from tail skin of adult AC5 KO and WT mice. The third
passage cells were exposed to 25 mM H2O2 or 25 mJ/
cm2 UV for 24 hr. Similar to MEFs, WT fibroblasts were
more sensitive to H2O2 and UV light, whereas AC5 KO fi-
broblasts displayed increased resistance to both H2O2
and UV light (data not shown). H2O2- or UV-light-treated
MEFs and adult fibroblasts were also subjected to apo-
ptosis analysis. Apoptosis was lower in AC5 KO than in
WT MEFs (Figure 4B, left) and adult fibroblasts (Fig-
ure 4B, right). These results indicate that disruption of
AC5 enhances resistance to oxidative stress in vitro. In
order to examine the mechanisms which confer resis-
tance to oxidative stress, we examined the levels of the
antioxidant MnSOD in heart, kidney, brain, and bone by
western blotting. The protein level of MnSOD was in-
creased in the heart, kidney, and brain of aging AC5
KO mice, providing further evidence that the AC5 KO
mice are resistant to oxidative damage (Figure 4C).The Raf/MEK/ERK Signaling Is Stimulated
in AC5 KO Mice
To investigate the molecular mechanisms mediating lon-
gevity in AC5 KO mice, we utilized an unbiased proteomic
analysis to search for novel proteins that are altered inAC5
KO mice. We initially separated proteins from brain tissue
using 2D gel electrophoresis and compared the gel pat-
terns of WT and AC5 KO mice (20 months old). We found
that nine proteins were upregulated, five downregulated,
and three altered by posttranslational modifications in
AC5KO mice (Table S1). Among these changes, we are in-
terested in the alteration which is shown in Figure 5A; the
pattern of spots in the circles was different between WT
and AC5 KO. The two spots in WT and one in AC5 KO
were observed, and all of them were identified as mito-
gen-activated protein kinase kinase 1 (MEK1; Figure S3)
using peptide mapping by mass spectrometry and se-
quence database searches, which suggests the alteration
of MEK1 posttranslational modification (most likely phos-
phorylation) in AC5 KO mice.
Since we observed alterations of MEK1 in AC5 KO mice
from 2D gel electrophoresis, we examined the levels of
p-MEK by western blotting in the heart. p-MEK was con-
firmed to be elevated in the heart of AC5 KO mice (Fig-
ure 5B). Furthermore, we examined its upstream molecule,
Raf-1, and its downstream molecule, ERK, by western
blotting. We found that phosphorylation of ERK was signif-
icantly increased in the heart and kidney (Figure 5C). Phos-
phorylation of Raf-1 was also elevated (data not shown).
The phosphorylation of ERK was also elevated in MEFs
isolated from AC5 KO mice (Figure 5C, right). Therefore,
Raf/MEK/ERK signaling is upregulated in AC5 KO mice.
ERK Mediates Resistance to Oxidative Stress
and Upregulation of SOD in AC5 KO Mice
We hypothesized that knocking outAC5 enhances cellular
resistance to oxidative stress through activation of ERK.Cell 130, 247–258, July 27, 2007 ª2007 Elsevier Inc. 249
To test this hypothesis, we inhibited ERK with PD98059
(the levels of p-ERK were significantly reduced after treat-
ment; data not shown), a specific inhibitor, to examine
whether inhibition of ERK reduces oxidative stress toler-
ance in AC5 KO mice. AC5 KO MEFs were pretreated
with PD98059 (30 mM in 0.04% DMSO and 60 mM in
0.08% DMSO) for 30 min before 24 hr incubation with 50
mM or 100 mM H2O2. The proportion of surviving cells pre-
treated with PD98059 was lower than the cells with vehicle
treatment alone (Figure 5D, left and middle), indicating
a possible role of ERK activation in mediating resistance
to oxidative stress. To further confirm whether ERK is in-
volved in stress resistance downstream of AC5, we used
RNAi to knock down ERK1 and ERK2 in AC5 KO MEFs
(the levels of p-ERK were significantly reduced after
treatment; data not shown), and then cells were treated
with 400 mM H2O2. In an ERK knockdown experiment,
cell viability was reduced (Figure 5D, right). As shown in
Figure 5D, the reduction of tolerance to oxidative stress
was more in AC5 KO than in WT. To further test whether
MnSOD could be a downstream enzyme of the ERK sig-
naling pathway, we determined the level of MnSOD in
MEFs from WT and AC5 KO mice treated with PD98059
and ERK siRNA. As shown in Figure 5E, the level of
MnSOD was reduced in MEFs pretreated with PD98059
Figure 3. AC5 KO Mice Are Protected from Aging Cardiomy-
opathy
Comparison of LVW/BW (A), LV ejection fraction (B), LV apoptosis (C),
and LV fibrosis (D) inAC5WT and KO, young (3–6 months, n = 4–9) and
old (20–30 months, n = 4–9). There were no significant differences
between young WT and young AC5 KO mice. However, all of the
four parameters were significantly different in old WT compared with
young WT (*p < 0.05), characteristic of aging cardiomyopathy. In con-
trast, none of the four parameters were different in old versus young
AC5 KO, but all four parameters were significantly different in old
AC5 KO versus old WT (**p < 0.05). For panels (A)–(D), all data are
expressed as mean ± SEM.250 Cell 130, 247–258, July 27, 2007 ª2007 Elsevier Inc.(left) and in MEFs with ERK siRNA (right), suggesting
that ERK plays an essential role in mediating upregulation
of MnSOD.
Overexpression of Mammalian ERK2 in Budding
Yeast Results in Extended Lifespan and Resistance
to Heat Shock and Oxidative Stress
To study the effects of the Raf/MEK/ERK pathway on
longevity, we overexpressed human ERK2 in yeast
(Figure 6A) since expression of human ERK in yeast can
partially substitute for the absence of KSS1, the ortholog
of ERK (Atienza et al., 2000). We found that ERK2 overex-
pressing yeast strains were resistant to heat shock and
oxidative stress (Figure 6B), and chronological lifespan
was longer compared to a WT strain that does not express
ERK2, e.g., the survival at 5 days in the strain with ERK2
overexpression was 62 ± 3.2%, significantly greater, p <
0.05, than WT (51 ± 4.4%; Figure 6C). We expressed
ERK2 also in strains that have a mutation in the gene en-
coding adenylyl cyclase, CYR1 (mutant: cyr1-1; Fabrizio
et al., 2001). The cyr1-1 mutant strain expressing ERK2
was not more resistant to heat shock and oxidative stress
compared to the nonERK2-expressing cyr1-1 mutant
strain (Figure 6B), and also the chronological lifespan
was not increased significantly (Figure 6C). Furthermore,
when we deleted KSS1 (ERK homolog gene) from the
yeast, the yeast strains lacking Kss1p showed increased
sensitivity to heat shock and oxidative stress (Figure 6D)
and a shorter lifespan, e.g., the survival at 5 days in the
strain lacking Kss1p was 36 ± 1.5%, significantly less,
p < 0.05, than WT (53 ± 2.1%; Figure 6E). Lack of Kss1p
also increases sensitivity to heat shock and oxidative
stress in a mutant cyr1-1 strain (Figure 6D) with a concom-
itant decrease in chronological lifespan, e.g., the survival
at 5 days in a mutant cyr1-1 strain lacking Kss1p was
69 ± 2.5%, significantly less, p < 0.05, than the cyr1-1
strain (90 ± 5.2%; Figure 6E). The data for all survival
results at 5 days and statistics are included in Table S2.
These results are consistent with the notion that the corre-
sponding Raf/MEK/ERK signaling pathway in yeast
(Ste11/Ste7/Kss1) interacts genetically with the Cyr1/
cAMP/PKA pathway in mediating regulation of lifespan
and stress resistance. It should be noted that our results
also suggest that the effect of Cry1-1 mutation could be
mediated by Kss1-independent mechanisms as well.
DISCUSSION
The central finding in this work is that AC5 KO mice exhibit
extended lifespan. Our observation for the first time indi-
cates that AC is not only a fundamentally important mech-
anism regulating lifespan in a wide variety of organisms
but also provides a novel molecular mechanism by which
genetic deletion of AC5 leads to this lifespan extension.
AC is the keystone of sympathetic transmission in b-AR
signaling in myocardium. The sympathetic nervous sys-
tem is designed to respond to stress. The activity of
the sympathetic nervous system and b-AR stimulation
Figure 4. AC5 KO Mice Are Resistant to Oxidative Stress
(A) Cell viability was evaluated in response to oxidative stress in neonatal cardiac myocytes and MEFs isolated from AC5 KO and WT mice. Myocytes
were treated with H2O2 (25, 50, and 100 mM) (upper left) or UV (10 and 25 mJ/cm
2; lower left) and evaluated for cell viability using CellTiter-Blue Cell
Viability Assay. AC5 KO neonatal myocytes showed more tolerance to oxidative and DNA damage (*p < 0.05 versus WT). MEFs were treated with
H2O2 (50, 100, 200, and 400 mM; upper right) or UV (25 and 100 mJ/cm
2; lower right) and evaluated for survival rate using trypan blue exclusion.
AC5 KO MEFs showed more tolerance to oxidative and DNA damage (*p < 0.05 versus WT). Data are expressed as mean ± SEM.
(B) Apoptosis was analyzed in response to UV or H2O2 in MEFs and adult fibroblasts isolated from AC5 KO and WT mice by histone-associated DNA
fragmentation using Cell Death Detection ELISA. Apoptosis was lower in AC5 KO than in WT MEFs and adult fibroblasts (*p < 0.05), indicating more
tolerance to oxidative and DNA damage in AC5 KO than in WT mice. Data are expressed as mean ± SEM.
(C) Western blotting of MnSOD from the heart, brain, and kidney ofAC5WT and KO mice (20 months, n = 4). The level of MnSOD is significantly greater
in the heart, brain, and kidney of AC5 KO mice compared to WT mice (*p < 0.05). Data are expressed as mean ± SEM.Cell 130, 247–258, July 27, 2007 ª2007 Elsevier Inc. 251
Figure 5. The Raf/MEK/ERK Pathway Plays an Essential Role in Mediating Stress Resistance in AC5 KO Mice
(A) 2D gel images from brain protein extracts of AC5 WT (top left panel) and KO mice (top right panel). The lower panel shows a magnified gel region
from WT (left) and AC5 KO (right). Gels were stained by SYPRO Ruby and quantified by Compugen Z3 software. The circled spots show an alteration
in the pattern of protein migration between WT and AC5 KO mice, which were later identified as MEK1 by peptide mass mapping using MALDI TOF
mass spectrometry and protein database search (Figure S3).
(B) Western blotting of p-MEK in the heart of AC5 WT and KO mice (20 months, n = 4 in each group). The level of p-MEK is significantly increased in
AC5 KO mice, *p < 0.05. Data are expressed as mean ± SEM.
(C) Western blotting of p-ERK in the heart and kidney of AC5 WT and KO mice (20 months, n = 4 in each group). The levels of p-ERK are significantly
increased in old AC5 KO mice for both kidney and heart, *p < 0.05. The levels of p-ERK are also increased in MEFs. Data are expressed as mean ±
SEM.
(D) The cell viability ofAC5WT and KO MEFs pretreated with PD98059 (30 mM and 60 mM) for 30 min before 24 hr incubation with 50 mM (left) or 100 mM
H2O2 (middle). MEFs were isolated from three KO and two WT mice. Two cell viability data points from each animal in each group at different con-
centrations of PD98059 were used to create graph and regression lines. The regression lines were compared statistically for differences in the slope
using ANCOVA. Clearly, the cell viability in the presence of PD98059 was lower than that without PD98059. The differences between the slopes are252 Cell 130, 247–258, July 27, 2007 ª2007 Elsevier Inc.
Figure 6. The Cyr1/cAMP/PKA Pathway
and theRaf/MEK/ERKPathwayAre Inter-
acting Genetically in the Regulation of
Resistance to Heat Shock and Oxidative
Stress and in Controlling Chronological
Lifespan
(A) ERK2 is expressed from a yeast plasmid
and regulated by the ADH1 promoter. WT cells
were transformed with an empty plasmid
and ERK2-expressing plasmid. Expression of
ERK2 was examined by western blotting (upper
panel). The lower left panel is a Coomassie-
stained gel.
(B) Yeast strains (WT, WT expressing ERK2 in
a plasmid, cyr1-1 mutant cells, and cyr1-1 mu-
tant cells expressing ERK2) were incubated at
55C for five minutes or incubated in the pres-
ence of 25 mM hydrogen peroxide (H2O2) at
30C for 30 min.
(C) Chronological lifespan was determined
from a WT strain, a WT strain expressing
ERK2 on a plasmid (pl), a cyr1-1 mutant strain,
and a cyr1-1 mutant strain expressing ERK2.
Standard errors are shown. The median life-
spans are: WT (5.1 days), WT ERK2 (6.3
days), cyr1-1 (7.5 days), and cyr1-1 ERK2 (7.8
days). Data are expressed as mean ± SEM.
(D) Yeast strains (WT, cyr1-1, kss1, and kss1
cyr1-1 mutant cells) were incubated at 55C
for five minutes or incubated in the presence
of 25 mM hydrogen peroxide (H2O2) at 30
C
for 30 min.
(E) Chronological lifespan determination of WT,
cyr1-1, kss1, and kss1 cyr1-1 mutant cells.
Standard errors are shown. The median life-
spans are: WT (6 days), cyr1-1 (7.7 days),
kss1 (4.5 days), and kss1 cyr1-1 (6.4 days).
Data are expressed as mean ± SEM.increases with aging and may play a role in the develop-
ment of aging cardiomyopathy (Lakatta, 1993; Swynghe-
dauw et al., 1995). For these reasons, it has been thought
that desensitization in the b-AR signaling pathway is pro-
tective in aging cardiomyopathy (Asai et al., 1999). b-AR
blockers improve survival after myocardial infarction,
have salutary effects in patients with heart failure, and
may have antiatherosclerosis effects. On the other hand,chronically enhanced b-AR stimulation with age is delete-
rious to the heart; indeed a number of mouse models of in-
creased b-AR stimulation at the level of the receptor (Du
et al., 2000; Engelhardt et al., 1999; Liggett et al., 2000),
G protein (Iwase et al., 1996), or PKA (Antos et al., 2001)
have been shown to have increased mortality and de-
creased resistance to stress. The effect of chronic inhibi-
tion of b-AR signaling upon aging of the heart has notsignificant, p < 0.05, as denoted by the asterisks, indicating that the reduction of tolerance to oxidative stress was greater in AC5 KO than in WT. The
cell viability of AC5 WT and KO MEFs with ERK1 and ERK2 knockdown using ERK siRNA and then incubation with 400 mM H2O2 are shown (right).The
cell viability with ERK1 and ERK2 knockdown was less than that without ERK1 and ERK2 knockdown. These observations demonstrate that inhibition
of ERK activation reduces the tolerance to different concentrations of oxidative stress. Data are expressed as mean ± SEM.
(E) Western blotting of MnSOD from MEFs of WT andAC5KO mice with and without PD98059 (left) and with and without ERK siRNA (right). The level of
MnSOD was reduced in MEFs pretreated with PD98059 and ERK siRNA.Cell 130, 247–258, July 27, 2007 ª2007 Elsevier Inc. 253
been examined using specific loss-of-function models.
The protection of AC5 KO mice from both aging cardio-
myopathy (LVH, fibrosis, and apoptosis; this study) and
stresses (pressure overload and chronic catecholamine
stimulation; our previous studies in Okumura et al.,
2003a, 2003c) may result from a desensitization of b-AR
signaling in the heart since AC5 is a major isoform of AC
in cardiac myocardium.
It is generally believed that lifespan of the organism is
regulated by key, evolutionarily conserved, molecular
mechanisms, such as sirtuin family proteins and FOXO
family transcription factors. Although it has been shown
that the genetic mutations in the cAMP-PKA pathway ex-
tend both replicative and chronological lifespan in yeast
(Fabrizio et al., 2001; Lin et al., 2000), whether or not
similar mechanisms regulate lifespan of mammals is a
critically important issue, which remains to be demon-
strated. Our observation clearly indicates that genetic
deletion of AC5, a mammalian homolog of yeast Cyr1,
extends the lifespan of mice.
To investigate the molecular mechanisms in the regula-
tion of longevity in AC5 KO mice, an unbiased proteomic
analysis followed by confirmation by western analysis
demonstrated activation in the Raf/MEK/ERK signaling
pathway. Previous findings suggested that activation of
the Raf/MEK/ERK pathway declines with age (Ajuh et al.,
2000; Hutter et al., 2000; Lorenzini et al., 2002; Meloche
et al., 2000; Miller et al., 1997; Torres et al., 2003; Zhen
et al., 1999). Increased levels of p-ERK were found in
long-lived CR mice (Ikeyama et al., 2002) and Snell dwarf
mice (Madsen et al., 2004). ERK has also been considered
as a cardioprotective agent in aged myocardium (Taylor
and Starnes, 2003). All of these results are consistent
with a notion that the Raf/MEK/ERK pathway is critical in
the aging process. However, a beneficial effect of ERK
in longevity has not been investigated previously.
We used yeast as a model to investigate the role of
Raf/MEK/ERK activation in longevity. Overexpression of
human ERK2 in a yeast strain caused extended chrono-
logical lifespan and stress resistance, strongly suggesting
that the mammalian ERK functions in controlling lifespan.
Furthermore, lack of Kss1p, an ERK2 homolog in yeast,
significantly reduced the lifespan and resistance to heat
and oxidative stress in the cyr1-1 mutant, consistent
with the notion that ERK2 homologs play an essential
role in mediating lifespan extension in the cyr1-1 mutant.
It should be noted, however, that a parallel pathway, pre-
sumably another yeast homolog of mammalian ERKs or
even ERK-independent mechanisms, may also regulate
lifespan and resistance to oxidative stress and heat
because the KSS1 deletion generated upon the cyr1-1
mutant showed significantly longer lifespan than the
KSS1 deletion alone.
Another important finding is thatAC5KO mice are resis-
tant to oxidative stress. Apoptosis, which may result from
oxidative damage, was reduced in the myocardium of
AC5 KO mice compared to WT mice, and molecular
mechanisms to be involved in protection against apopto-254 Cell 130, 247–258, July 27, 2007 ª2007 Elsevier Inc.sis, p-Bad, Bcl-xl, Hsp70, and XIAP, were increased not
only in heart but also in kidney and brain. Resistance to
oxidative stress has been identified in some longevity
mouse models; e.g., IGF-1-receptor-deficient mice (Hol-
zenberger et al., 2003), p66Shc/ mice (Migliaccio et al.,
1999), mice with overexpression of mitochondria-specific
catalase (Schriner et al., 2005), Snell and Ames dwarf mice
(Murakami et al., 2003; Romanick et al., 2004), and CR
mice (Sohal and Weindruch, 1996). In addition, increased
lifespan in nematodes (Feng et al., 2001; Ishii, 2000; Lith-
gow, 1996) and Drosophila (Morrow et al., 2004) also has
been attributed at least in part to increased resistance to
oxidative stress. The Raf/MEK/ERK signaling pathway is
one of the central mediators in response to oxidative dam-
age (Finkel and Holbrook, 2000; Yoon et al., 2002). Activa-
tion of the ERK pathway in response to oxidative stress is
reduced with age, and the loss of oxidative stress toler-
ance with age is linked to reduced ERK activity (Ikeyama
et al., 2002). These findings suggest that the increased
ERK activation in AC5 KO mice may result in an increased
tolerance to oxidative stress. Our data indicate that
MnSOD expression is reduced when ERK activation is
inhibited, suggesting that MnSOD could be a downstream
effector of the ERK signaling pathway. We suggest that
knocking out AC5 activates ERK signaling, which, in
turn, promotes the upregulation of MnSOD, leading to
resistance to oxidative stress (Figure 7).
Development of osteoporotic and osteosclerotic bone,
demonstrated by loss of the nonweight-bearing fibula, is
commonly observed in inbred and outbred mice as they
approach two years of age (Globocnik and Rajtova,
1978; Loutit et al., 1976) and is similar to our observations
made in the old WT mice. In contrast, bone quality was
preserved in the old female AC5 KO mice. In osteoblasts,
ERK activation has been associated with proliferation,
mechanical responsiveness, and differentiation (Kapur
et al., 2004; Lai et al., 2001). Furthermore, ERK signaling
is necessary for bone morphogenetic protein-induced os-
teoblast differentiation (Gallea et al., 2001). Thus, loss of
AC5 function leads to enhanced osteoblast function
through ERK activation. In the current investigation, we
observed protection against adverse effects of aging on
bone and on the heart, and we also observed similar cel-
lular mechanisms in kidney and brain. However, it is con-
ceivable that the protective mechanisms observed in AC5
KO mice are not expressed in all tissues.
The mechanism for longevity has been studied most
extensively in CR (Sinclair, 2005). Like mice with CR, old
AC5 KO mice exhibit lower body weights. Interestingly,
the food intake in young AC5 KO mice was enhanced,
suggesting that lifespan extension in AC5 KO mice may
not be mediated by reduced caloric intake in young ani-
mals, although we cannot exclude the possibility that
AC5 KO may cause a reduction in food intake in later
stages of life, thereby mimicking CR. Alternatively, AC5
KO may induce metabolic effects similar to CR, which
stimulates the eating behavior of young AC5 KO mice. In
fact, inhibition of the cAMP-PKA pathway and CR function
in the same pathway to extend replicative lifespan in
yeast, and mutations that decrease PKA have been sug-
gested as genetic models of CR (Lin et al., 2000). Thus,
further investigation will be required to determine whether
AC5 KO and CR utilize a common mechanism for lifespan
extension in mice.
Review of the literature and our own preliminary studies
indicate that with the exception of particular neoplasms
that vary from mouse strain to strain, the pathology at
the time of death is quite diverse (Chrisp et al., 1996;
Storer, 1966; Wolf et al., 1988). Malignant lymphoma
and alveologenic neoplasms are the principle causes of
death in the C57BL/6J strain (Wolf et al., 1988). One of
few studies of 129/SvJ mice (Storer, 1966) summarized
the major pathology of the mice as ‘‘nonspecific’’ with tu-
mors in 20% of females and 10% of males. The summary
of tumor incidence in mouse strains from Jackson Lab
(Naf et al., 2002) indicates five organs with moderate
tumor incidence in 129/SvJ mice: mammary gland,
Figure 7. The Proposed MechanismMediating Longevity and
Stress Resistance in AC5 KO Mice
Knocking out AC5 activates the Raf/MEK/ERK signaling pathway. The
activation of ERK activates antioxidative stress, antiapoptosis, and cell
survival mechanisms, which lead to longevity in AC5 KO mice. The
arrows indicate the direction of signaling ([ indicates increase, and
Y indicates decrease).lymphohematopoietic, lung, liver, and vulva. By autopsy
of mice with 129/SvJ-C57BL/6J strain, we observed that
lymphoma was a common tumor in WT, and this type of
tumor was ameliorated in AC KO mice (unpublished
data). Cancer protection has also been observed in other
longevity models, e.g., CR and GH/IGF-I deficiency (Yang
et al., 2005; Zhu et al., 2005). The mechanism of lifespan
extension in AC5 KO mice is still not established, but
delayed tumor incidence compared to WT mice could
be one mechanism, whereas protection against the car-
diomyopathy of aging could be another.
In summary, the data from the current investigation sug-
gests that disruption of AC5 mediates activation of the
Raf/MEK/ERK signaling pathway and results in protection
from oxidative stress, apoptosis, and osteoporosis, lead-
ing to longevity inAC5KO mice (Figure 7). Aging increases
the susceptibility of organs to various age-related dis-
eases. Retarding the aging of the individual organ could
be a fundamental therapy to prevent age-related dis-
eases. AC5 could be a novel target to prevent age-related
heart disease and possibly prolong the lifespan of humans.
EXPERIMENTAL PROCEDURES
Generation of Knockout Mice
The AC5 gene was disrupted by deleting the exon with the first trans-
lation initiation site using homologous recombination as described
previously (Okumura et al., 2003c). All mice were 129/SvJ-C57BL/6
mixed-background littermates from F1 heterozygote crosses. Equal
numbers of male and female mice were studied, except for the bone
integrity experiments, where only female mice were studied. This study
was approved by the Institutional Animal Care and Use Committee at
New Jersey Medical School.
Evaluation of Bone Integrity
The X-ray radiography was taken for the comparison of bone density,
healing stress fracture, and calcification between WT and AC5 KO
mice. Femur structural properties (peak torque) and material pro-
perties (shear stress and shear modulus) were determined from
the force-displacement curves and bone dimensions as previously
described (Manigrasso and O’Connor, 2004).
Measurement of GH Level
GH level was measured using a Mouse/Rat GH ELISA Kit from Diag-
nostic Systems Laboratories (Webster, TX).
Evaluation of Apoptosis
DNA fragmentation was detected in situ using terminal deoxynucleoti-
dyltransferase-mediated dUTP nick end labeling (TUNEL) staining, as
published previously (Geng et al., 1999).
2D Gel Electrophoresis and Protein Identification
Brain tissues from 20-month-old AC5 KO and WT mice were homog-
enized in a 2D compatible buffer (7 M urea, 2 M thiourea, 4% CHAPS,
0.5% Biolytes, 1% Triton, 1% DTT, and phosphatase and protease
inhibitors) and centrifuged at 12,000 3 g for 30 min at 4C, and the
protein concentration was determined using the Bradford method.
Proteins were separated in the first dimension according to their iso-
electric point by isoelectric focusing (IEF) and then resolved in the sec-
ond dimension, according to the molecular weight by SDS-PAGE. IEF
was performed using Immobilized pH Gradient (IPG) strips with a pH
range of 5–8 on a BioRad IEF cell with a programmed voltage gradient.
SDS-PAGE was performed on a 12.5% polyacrylamide gel. Gels wereCell 130, 247–258, July 27, 2007 ª2007 Elsevier Inc. 255
stained with SYPRO Ruby (Bio-Rad) and scanned with a Typhon 9400
imager (Amersham Biosciences). 2D gel spots of interest were
excised, destained, and digested with modified trypsin. In gel tryptic
digests were extracted and analyzed by ABI 4700 MALDI-TOF/TOF
mass spectrometers. Spectra were acquired, and measured peptide
masses were searched in the NCBlnr protein sequence database us-
ing the MS-Fit and ProFound search engines with a mass tolerance
of 50 ppm and a required four peptide minimum match.
Western Blotting
The blots were probed with primary antibodies incubated overnight at
4C. The immunopositive bands were visualized by using Western
Lightning chemiluminescence reagent (Perkin Elmer Life Sciences,
MA). All western blot exposures were in the linear range of detection,
and the intensities of the resulting bands were quantified by Quantity
One software on GS-800 densitometer (Bio-Rad).
Primary Culture of Neonatal Mouse Ventricular Myocytes
and Oxidative Stress Treatment
Primary cultures of ventricular cardiac myocytes were prepared from
1-day-old AC5 KO and WT mice. Briefly, ventricular myocytes were
enzymatically dissociated and preplated for 1 hr to enrich for myo-
cytes. Cells were plated onto either gelatin-coated 60 mm culture
dishes or coverslips and cultured in cardiac myocyte culture media
containing DMEM/F-12 supplemented with 5% horse serum, 4 mg/ml
transferrin, 0.7 ng/mL sodium selenite (GIBCO BRL), 2 g/L bovine se-
rum albumin (fraction V), 3 mM pyruvic acid, 15 mM HEPES (pH 7.6),
100 mM ascorbic acid, 100 mg/ml ampicillin, 5 mg/ml linoleic acid,
and 100 mM 5-bromo-20-deoxyuridine (Sigma Chemical Co.). Culture
media was changed to serum-free media after 24 hr. Myocytes were
further cultured under serum-free conditions for 48 hr before experi-
ments. We obtained myocyte cultures in which more than 95% are
myocytes, as assessed by immunofluorescence staining with a mAb
against sarcomeric myosin (MF20). After culturing for 48 hr, myocytes
were treated by UV (10 and 25 mJ/cm2) and H2O2 (25–100 mM) and
evaluated for cell viability using CellTiter-Blue Cell Viability Assay
(Promega Co., Madison, WI).
Primary Culture of Fibroblasts and Oxidative Stress Treatment
MEFs were isolated from embryos of homozygous AC5 KO mice or
AC5 WT mice. Mouse adult skin-derived fibroblasts were isolated
from tails of homozygous AC5 KO mice or AC5 WT mice. The geno-
types of MEFs were identified by PCR analysis using genomic DNA.
The fibroblasts were expanded for another two passages before
use. All fibroblasts were cultured in complete DMEM (Dulbecco’s
modified Eagle’s medium) with high glucose (Hyclone) containing
10% FBS, 200 mM L-glutamine, and 1% penicillin-streptomycin. The
third passage cells were treated by H2O2 (25–400 mM) or UV light
(25–500 mJ/cm2). Cell survival rate was determined after 1–2 days
using trypan blue exclusion method. Histone-associated DNA frag-
mentation was analyzed for apoptotic cell death by ELISA (Cell Death
Detection ELISA Plus, Roche).
ERK1 and ERK2 siRNA Transfection
ERK1 (sc-29308) and ERK2 (sc-35336) siRNA from Santa Cruz Bio-
technology were used to knock down gene expression of ERK1 and
ERK2 in AC5 MEFs. Briefly, in a 96-well tissue culture plate, 1.3 3
104 cells were seeded per well in antibiotic-free normal growth medium
supplemented with FBS. The cells were incubated at 37C until 60%–
80% confluent. Cells were then incubated at room temperature for 5
min with Lipofectamine 2000 (0.94 ml) and OPTI medium (9.4 ml). siRNA
control (sc-37007; 40 ml) or of ERK1 (20 ml) and of ERK2 (20 ml) siRNA
was then added, and cells were incubated for an additional 20 min. The
cells were washed with 200 ml OPTI medium. 94 ml of OPTI medium
was added to the well, followed by siRNA transfection mixture, and
incubated for 4 hr at 37C. This mixture was then replaced by normal
growth medium and incubated for 50 hr. The cells were treated over-256 Cell 130, 247–258, July 27, 2007 ª2007 Elsevier Inc.night with 100 ml 2% FBS growth medium containing different concen-
trations of H2O2 and were then analyzed for viability.
Yeast Methods
The cyr1-1 mutant strain and its corresponding WT strain were used
(Fabrizio et al., 2001). The cDNA encoding ERK2 was inserted into
the YEplac195 plasmid (containing a LEU2 gene); ERK2 is under the
control of the ADH1 promoter (YEplac195-ADH-ERK2). Expression
levels were tested by western blotting analysis using polyclonal anti-
bodies against ERK2 protein. The YEplac195-ADH (empty plasmid)
and YEplac195-ADH-ERK2 plasmids were transformed into both
a WT and a cyr1-1 mutant yeast strain. The plasmids were maintained
in a complete synthetic medium lacking leucine (YC-Leu). The ORF of
the KSS1 gene was knocked out precisely by gene disruption using
a HIS3 marker gene. Yeast strains were tested for responses to differ-
ent stresses: cells were incubated for 5 min at 55C or in the presence
of 25 mM hydrogen peroxide at 30C for 30 min. Chronological lifespan
was determined as previously described (Fabrizio et al., 2003; Sun
et al., 2002). Experiments were repeated four times.
Statistical Analysis
Data are expressed as mean ± SEM. For comparison of two groups,
Student’s t test was used. Survival curves were compared using Chi
Square, Kaplan-Meier survival analysis or ANOVA with Fisher’s
PLSD test. Regression lines were compared for differences in slope
using the Analysis of Covariance (ANCOVA). Significance was
accepted at p < 0.05.
Supplemental Data
Supplemental Data include two tables and four figures and can be
found with this article online at http://www.cell.com/cgi/content/full/
130/2/247/DC1/.
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